Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.62M | -1.62M | -1.60M | -1.42M | -1.23M |
| Total Depreciation and Amortization | 139.60K | 138.80K | 137.20K | 123.00K | 108.00K |
| Total Amortization of Deferred Charges | 110.10K | 69.60K | 28.40K | 38.20K | 48.10K |
| Total Other Non-Cash Items | 318.00K | 275.80K | 233.30K | 199.50K | 163.60K |
| Change in Net Operating Assets | -609.20K | -450.50K | -294.70K | 144.10K | 588.30K |
| Cash from Operations | -1.67M | -1.58M | -1.49M | -912.50K | -322.00K |
| Capital Expenditure | -3.80K | -7.60K | -11.20K | -23.40K | -35.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.10K | -303.10K | -447.70K | -587.40K | -726.10K |
| Cash from Investing | -157.90K | -310.70K | -458.90K | -610.80K | -761.70K |
| Total Debt Issued | 72.00K | 161.00K | 250.00K | 625.00K | 1.00M |
| Total Debt Repaid | -127.00K | -142.50K | -158.00K | -378.00K | -598.00K |
| Issuance of Common Stock | 1.89M | 1.89M | 1.89M | 943.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -500.00 | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -193.00K | -193.00K | -193.00K | -96.50K | 0.00 |
| Cash from Financing | 2.06M | 2.15M | 2.24M | 1.37M | 482.40K |
| Foreign Exchange rate Adjustments | 39.00K | 27.70K | 16.40K | 2.20K | -12.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 270.60K | 281.90K | 301.20K | -152.40K | -613.40K |